Eli Lilly benefits from rising cash flow and a strong pipeline, yet elevated pricing versus peers limits near-term gains. See ...

Patients regularly taking Eli Lilly & Co.’s obesity shot Zepbound tend to keep the weight off for at least three years, with ...

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

In an interview, the US pharmaceuticals giant’s international chief says Australia has made no progress in making life easier for medicine developers.

Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...

In the Phase 2 ALPACA study, lepodisiran significantly reduced ... Annual Meeting taking place March New results show Eli Lilly and Company's (NYSE: LLY) EBGLYSS achieved deep and sustained ...

Pfizer will halt its development of a weight-loss drug that was being closely watched by investors, in a significant blow to the US pharmaceutical group. The company said on Monday that it would stop ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

Senator John Fetterman, a democrat from Pennsylvania, admitted to using weight loss drug Mounjaro and issued a desperate plea ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, swelling that can be caused by cancer treatment.